A review of the literature concerning HIV and cigarette smoking: Morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts

Addiction Research and Theory

Volumn 23, Issue 1, 2015, Pages 10-23

  Pacek, Lauren R ^a   Crum, Rosa M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cessation; Cigarette smoking; HIV; Morbidity; Mortality

Indexed keywords

EID: 84920774346     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.3109/16066359.2014.920013     Document Type: Review

References (107)

1. Alexander, C., Piazza, M., Mekos, D., & Valente, T. (2001). Peers, school, and adolescent cigarette smoking. Journal of Adolescent Health, 23, 22-30.
2. Arcavi, L., & Benowitz, N.L. (2004). Cigarette smoking and infection. Archives of Internal Medicine, 164, 2206-2216.
3. Aubin, H.-J., Bobak, A., Britton, J.R., Oncken, C., Billing Jr, C.B., Gong, J., ... Reeves, K.R. (2008). Varenicline versus transdermal nicotine patch for smoking cessation: Results from a randomised open-label trial. Thorax, 63, 717-724.
4. Barbaro, G., Di Lorenzo, G., Cirelli, A., Grisorio, B., Lucchini, A., Hazra, C., & Barbarini, G. (2003). An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy. Clinical Therapeutics, 25, 2405-2418.
5. Benard, A., Bonnet, F., Tessier, J., Fossoux, H., Dupon, M., Mercie, P., ... Chene, G. (2007). Tobacco addiction and HIV infection: Toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care and STDs, 21, 458-468.
6. Bing, E.G., Burnam, M.A., Longshore, D., Fleishman, J.A., Sherbourne, C.D., London, A.S., ... Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721-728.
7. Boarts, J.M., Bogart, L.M., Tabak, M.A., Armelie, A.P., & Delahanty, D.L. (2008). Relationship of race, sexual orientation, and HIV-related discrimination with adherence to HIV treatment: A pilot study. Journal of Behavioral Medicine, 31, 445-451.
8. Bogart, L.M., Cogwill, B.O., Kennedy, D., Ryan, G., Murphy, D.A., Elijah, J., & Schuster, M.A. (2008). HIV-related stigma among people with HIV and their families: A qualitative analysis. AIDS and Behavior, 12, 244-254.
9. Burkhalter, J.E., Springer, C.M., Chabra, R., Ostroff, J.S., & Rapkin, B.D. (2005). Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine and Tobacco Research, 7, 511-522.
10. Centers for Disease Control and Prevention (CDC). (2011a). Current Cigarette Smoking Prevalence Among Working Adults - United States, 2004-2010. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6038a2.htm.
11. Centers for Disease Control and Prevention (CDC). (2011b). Tobacco use: Targeting the nation's leading killer at a glance 2011. Retrieved from http://www.cdc.gov/chronicdisease/resources/publications/aag/osh.htm.
12. Centers for Disease Control and Prevention (CDC). (2011c). Quitting smoking among adults - United States, 2001-2010. Retrieved from http://www.cdc.gov/tobacco/data-statistics/mmwrs/byyear/2011/mm6044a2/intro.htm.
13. Centers for Disease Control and Prevention (CDC). (2013). Quitting smoking. Retrieved from http://www.cdc.gov/tobacco/data-statistics/fact-sheets/cessation/quitting/index.htm#methods.
14. Chander, G., Stanton, C., Hutton, H.E., Abrams, D.B., Pearson, J., Knowlton, A., ... Niaura, R. (2012). Are smokers with HIV using information and communication technology? Implications for behavioral interventions. AIDS and Behavior, 16, 383-388.
15. Chaturvedi, A.K., Pfeiffer, R.M., Chang, L., Goedert, J.J., Biggar, R.J., & Engels, E.A. (2007). Elevated risk of lung cancer among people with AIDS. AIDS, 21, 207-213.
16. Cheong, Y., Yong, H.H., & Borland, R. (2007). Does how you quit affect success? A comparison between abrupt and gradual methods using data from the International Tobacco Control Policy Evaluation Study. Nicotine and Tobacco Research, 9, 801-810.
17. Christakis, N.A., & Fowler, J.H. (2008). The collective dynamics of smoking in a large social network. The New England Journal of Medicine, 358, 2249-2258.
18. Clifford, G.M., Lise, M., Franceschi, S., Egger, M., Bouchardy, C., Korol, D., ... Schöni-Affolter, F. (2012). Lung cancer in the Swiss HIV Cohort Study: Role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer, 106, 447-452.
19. Coates, R.A., Farewell, V.T., Raboud, J., Read, S.E., MacFadden, D.K., Calzavara, L.M., ... Fanning, M.M. (1990). Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. American Journal of Epidemiology, 132, 717-722.
20. Collins, R.L., Kanouse, D.E., Gifford, A.L., Senterfitt, J.W., Schuster, M.A., McCaffrey, D.F., ... Wenger, N.S. (2001). Changes in health-promoting behavior following diagnosis with HIV: Prevalence and correlates in a national probability sample. Health Psychology, 20, s351-s360.
21. Crothers, K., Goulet, J.L., Rodriguez-Barradas, M.C., Gibert, C.L., Butt, A.A., Braithwaite, R.S., ... Justice, A.C. (2007). Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. Journal of General Internal Medicine, 22, 749-754.
22. Crothers, K., Griffith, T.A., McGinnis, K.A., Rodriguez-Barradas, M.C., Leaf, D.A., Weissman, S., ... Justice, AC. (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. Journal of General Internal Medicine, 20, 1142-1145.
23. Cui, Q., Robinson, L., Elston, D., Smaill, F., Cohen, J., Quan, C., ... Smieja, M. (2011). Safety and tolerability of varenicline tartrate (champix(®)/chantix (®)) for smoking cessation in HIV-infected subjects: A pilot open-label study. AIDS Patient Care STDS, 26, 12-19.
24. Diemert, L.M., Bondy, S.J., Brown, K.S., & Manske, S. (2013). Young adult smoking cessation: Predictors of quit attempts and abstinence. American Journal of Public Health, 103, 449-453.
25. Elzi, L., Spoerl, D., Voggensperger, J., Nicca, D., Simcock, M., Bucher, H.C., ... Battegay, M., and the Swiss HIV Cohort Study. (2006). A smoking cessation programme inHIV-infected individuals: a pilot study. Antiviral Therapy, 11, 787-795.
26. Encrenaz, G., Rondeau, B.V., Bonnet, F., Lazaro, E., Neau, D., Dupon, M., ... Chene, G. (2010). Determinants of smoking cessation attempts among HIV-infected patients from a hospital-based prospective cohort. Current HIV Research, 8, 212-217.
27. Engels, E.A., Brock, M.V., Chen, J., Hooker, C.M., Gillison, M., & Moore, R.D. (2006). Elevated incidence of lung cancer among HIV-infected individuals. Journal of Clinical Oncology, 24, 1383-1388.
28. Feldman, J.G., Minkoff, H., Schneider, M.F., Gange, S.J., Cohen, M., Watts, H., ... Anastos, K. (2006). Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the Women's Interagency HIV Study. American Journal of Public Health, 96, 1060-1065.
29. Ferrando, S.J., & Freyberg, Z. (2008). Treatment of depression in HIV positive individuals: A critical review. International Review of Psychiatry, 20, 61-71.
30. Fiore, M. (2000). Treating tobacco use and dependence: An introduction to the US Public Health Service Clinical Practice Guidelines. Respiratory Care, 45, 1196-1199.
31. Fiore, M.C., Jaén, C.R., Baker, T.B., Bailey, W.C., Benowitz, N.L., Curry, S.J., Dorfman, S.F., ... Wewers, M.E. (2008). Treating tobacco use and dependence: 2008 update. Clinical practice guidelines. Rockville, MD: U.S. Department of Health and Human Services.
32. Food and Drug Administration. (2009). Public health advisory: FDA requires new boxed warnings for the smoking cessation drugs chantix and zyban. Retrieved from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm169988.htm.
33. Friis-Møller, N., Sabin, C.A., Weber, R., d'Arminio Monforte, A., El-Sadr, W.M., Reiss, P., ... Lundgren, J.D. (2003). Combination antiretroviral therapy and the risk of myocardial infarction. New England Journal of Medicine, 349, 1993-2003.
34. Furber, A.S., Maheswaran, R., Newell, J.N., & Carroll, C. (2007). Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systematic review. Sexually Transmitted Infections, 83, 41-46.
35. Fuster, M., Estrada, V., Fernandez-Pinilla, M.C., Fuentes-Ferrer, M.E., Teller, M.J., Vergas, J., ... Fernandez-Cruz, A. (2009). Smoking cessation in HIV patients: Rate of success and associated factors. HIV Medicine, 10, 614-619.
36. Galai, N., Park, L.P., Wesch, J., Visscher, B., Riddler, S., & Margolic, J.B. (1997). Effect of smoking on the clinical progression of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrivirology, 14, 451-458.
37. Goldberg, D., Weber, K.M., Orsi, J., Hessol, N.A., D'Souza, G., Watts, D.H., ... Cohen, M.H. (2010). Smoking cessation among women with and at risk for HIV: Are they quitting? Journal of General Internal Medicine, 25, 39-44.
38. Gonzales, D., Rennard, S.I., Nides, M., Oncken, C., Azoulay, S., Billing, C.B., ... Reeves, K.R. (2006). Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation. JAMA, 296, 47-55.
39. Gritz, E.R., Vidrine, D.J., & Fingeret, M.C. (2007). Smoking cessation: A critical component of medical management in chronic disease populations. American Journal of Prevention Medicine, 33, S414-S422.
40. Gritz, E.R., Vidrine, D.J., Lazev, A.B., Amick III, B.C., & Arduino, R.C. (2004). Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine and Tobacco Research, 6, 71-77.
41. Helleberg, M., Afzal, S., Kronborg, G., Larsen, C.S., Pedersen, G., Pedersen, C., ... Obel, N. (2013). Mortality attributable to smoking among HIV-1-infected individuals: A nationwide, population-based cohort study. Clinical Infectious Diseases, 56, 727-734.
42. Horvath, K.J., Eastman, M., Prosser, R., Goodroad, B., & Worthington, L. (2012). Addressing smoking during medical visits: Patients with human immunodeficiency virus. American Journal of Prevention Medicine, 43, S214-S221.
43. Humfleet, G.L., Delucchi, K., Kelley, K., Hall, S.M., Dilley, J., & Harrison, G. (2009). Characteristics of HIV-positive cigarette smokers: A sample of smokers facing multiple challenges. AIDS Education and Prevention, 21, 54-64.
44. Huttunen, R., Heikkinen, T., & Syrjanen, J. (2011). Smoking and the outcome of infection. Journal of Internal Medicine, 269, 258-269.
45. Ingersoll, K.S., Cropsey, K.L., & Heckman, C.J. (2009). A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS and Behavior, 13, 545-554.
46. Jorenby, D.E., Taylor Hays, J., Rigotit, N.A., Azoulay, S., Watsky, E.J., Williams, K.E., ... Reeves, K.R. (2006). Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation. JAMA, 296, 56-63.
47. Joseph, A.M., Hecht, S.S., Murphy, S.E., Lando, H., Carmella, S.G., Gross, M., ... Hatsukami, D.K. (2008). Smoking reduction fails to improve clinical and biological markers of cardiac disease: A randomized controlled trial. Nicotine and Tobacco Research, 10, 471-481.
48. Kirk, G.D., Merlo, C., O' Driscoll, P., Mehta, S.H., Vlahov, D., Samet, J., & Engels, E.A. (2007). HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clinical Infectious Diseases, 45, 103-110.
49. Kohli, R., Lo, Y., Homel, P., Flanigan, T.P., Gardner, L.I., Howard, A.A., ... Schoenbaum, E.E. (2006). Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clinical Infectious Diseases, 43, 90-98.
50. Kwong, J., & Bouchard-Miller, K. (2010). Smoking cessation for persons living with HIV: A review of currently available interventions. Journal of the Association of Nurses in AIDS Care, 21, 3-10.
51. Lazev, A.B., Vidrine, D.J., Arduino, R.C., & Gritz, E.R. (2004). Increasing access to smoking cessation treatment in a low-income, HIV-positive population: The feasibility of using cellular telephones. Nicotine & Tobacco Research, 6, 281-286.
52. Lazo, M., Gange, S.J., Wilson, T.E., Anastos, K., Ostrow, D.G., Witt, M.D., & Jacobson, L.P. (2007). Patterns and predictors of changes in adherence to highly active antiretroviral therapy: Longitudinal study of men and women. Clinical Infectious Diseases, 45, 1377-1385.
53. Levine, A.M., Seaberg, E.C., Hessol, N.A., Preston-Martin, S., Silver, S., Cohen, M.H., ... Watts, D.H. (2010). HIV as a risk factor for lung cancer in women: Data from the Women's Interagency HIV Study. Journal of Clinical Oncology, 28(9), 1514-1519.
54. Lewden, C., Salmon, D., Morlat, P., Bévilacqua, S., Jougla, E., Bonnet, F., ... Chêne, G. (2005). Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: Emerging role of hepatitis and cancers, persistent role of AIDS. International Journal of Epidemiology, 34, 121-130.
55. Lifson, A.R., Neuhaus, J., Arribas, J.R., van den Berg-Wolf, M., Labriola, A.M., & Read, T.R.H. (2010). Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial. American Journal of Public Health, 100, 1896-1903.
56. Lloyd-Richardson, E.E., Stanton, C.A., Papandonatos, G.D., Betancourt, R.E.M., Stein, M., Tashima, K., ... Niaura, R. (2008). HIV-positive smokers considering quitting: Differences by race/ethnicity. American Journal of Health Behavior, 32, 3-15.
57. Lloyd-Richardson, E.E., Stanton, C.A., Papandonatos, G.D., Shadel, W.G., Stein, M., Tashima, K., ... Niaura, R. (2009). Motivation and patch treatment for HIV+ smokers: A randomized controlled trial. Addiction, 104, 1891-1900.
58. Mamary, E.M., Bahrs, D., & Martinez, S. (2002). Cigarette smoking and desire to quit among individuals living with HIV. AIDS Patient Care and STDs, 16, 39-42.
59. Marshall, M.M., Kirk, G.D., Caporaso, N.E., McCormack, M.C., Merlo, C.A., Hague, J.C., ... Engels, E.A. (2011). Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addictive Behaviors, 36, 61-67.
60. Mermelstein, R., Cohen, S., Lichtenstein, E., Baer, J.S., & Kamarck, T. (1986). Social support and smoking cessation and maintenance. Journal of Consulting and Clinical Psychology, 54, 447-453.
61. Miguez-Burbano, M.J., Ashkin, D., Rodriguez, A., Duncan, R., Pitchenik, A., Quintero, N., ... Shor-Posner, G. (2005). Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. International Journal of Infectious Disease, 9, 208-217.
62. Mihalak, K.B., Carroll, F.I., & Luetje, C.W. (2006). Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors. Molecular Pharmacology, 70, 801-805.
63. Moadel, A.B., Bernstein, S.L., Mermelstein, R.J., Arnsten, J.H., Dolce, E.H., & Shuter, J. (2012). A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. Journal of Acquired Immune Deficiency Syndrome, 61, 208-215.
64. Modrich, L., Scherzer, R., Zolopa, A., Rimland, D., Lewis, C.E., Bacchetti, P., ... Tien, P.C. (2010). Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the HAART era. Journal of Acquired Immune Deficiency Syndrome, 53, 102-106.
65. Nakagawa, F., May, M., & Phillips, A. (2013). Life expectancy living with HIV: Recent estimates and future implications. Current Opinion in Infectious Disease, 26, 17-25.
66. Niaura, R., & Abrams, D.B. (2002). Smoking cessation: Progress, priorities, and prospectus. Journal of Consulting and Clinical Psychology, 70, 494-509.
67. Nieman, R.B., Fleming, J., Cocker, R.J., Harris, J.R., & Mitchell, D.M. (1993). The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS, 7, 705-710.
68. Oncken, C., Gonzales, D., Nides, M., Rennard, S., Watsky, E., Billing, C.B., ... Reeves, K. (2006). Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Archives of Internal Medicine, 166, 1571-1577.
69. Pacek, L.R., Latkin, C., Crum, R.M., Stuart, E.A., & Knowlton, A.R. (2013). Current cigarette smoking among HIV-positive current and former drug users: Associations with individual and social characteristics. AIDS and Behavior. [Epub ahead of print]. doi: 10.1007/s10461-013-0663-1.
70. Pacek, L.R., Latkin, C., Crum, R.M., Stuart, E.A., & Knowlton, A.R. (2014). Interest in quitting and lifetime quit attempts among smokers living with HIV infection. Drug and Alcohol Dependence, 138, 220-224.
71. Palefsky, J.M., Minkoff, H., Kalish, L.A., Levine, A., Sacks, H.S., Garcia, P., ... Burk, R. (1999). Cervicovaginal human papilloma- virus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Journal of the National Cancer Institute, 91, 226-236.
72. Palefsky, J.M., Shiboski, S., & Moss, A. (1994). Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. Journal of Acquired Immune Deficiency Syndrome, 7, 599-606.
73. Palella Jr, F.J., Baker, R.K., Moorman, A.C., Chmiel, J.S., Wood, K.C., Brooks, J.T., & Holberg, S.D. (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV out-patient study. Journal of Acquired Immune Deficiency Syndrome, 43, 27-34.
74. Palella Jr, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Atten, G.A., ... Holberg, S.D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338, 853-860.
75. Patel, P., Hanson, D.L., Sullivan, P.S., Novak, R.M., Moorman, A.C., Tong, T.C., ... Brooks, J.T. (2008). Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Annals of Internal Medicine, 148, 728-744.
76. Pedro-Clotet, E., Deig-Comerma, E., Ribell-Bachs, M., Vidal-Castell, I., García-Rodríguez, P., & Soler, A. (2006). Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy. Enfermedades Infecciosas y Microbiología Clínica, 24, 509-511.
77. Petoumenos, K., Worm, S., Reiss, P., de Wit, S., d'Arminio Monforte, A., Sabin, C., ... Law, M. (2011). Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D:A:D study. HIV Medicine, 12, 412-421.
78. Pines, H., Koutsky, L., & Buskin, S. (2011). Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996-2008). AIDS and Behavior, 15, 243-251.
79. Rabkin, J.G., Goetz, R.R., Remien, R.H., Williams, J.B., Todak, G., & Gorman, J.M. (1997). Stability of mood despite HIV illness progression in a group of homosexual men. American Journal of Psychiatry, 154, 231-238.
80. Reynolds, N.R., Neidig, J.L., & Wewers, M.E. (2004). Illness representation and smoking behavior: A focus group study of HIV-positive men. Journal of the Association of Nurses in AIDS Care, 15, 38-46.
81. Rice, V.H., Hartmann-Boyce, J., & Stead, L.F. (2013). Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews, Issue 8. Article Number: CD001188.
82. Riley, E.D., Gandhi, M., Hare, C., Cohen, J., & Hwang, S. (2007). Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS Reports, 4, 181-186.
83. Savès, M., Chêne, G., Ducimetière, P., Leport, C., Le Moal, G., Amouyel, P., ... Raffi, F. (2003). Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clinical Infectious Diseases, 37, 292-298.
84. Schane, R.E., Ling, P.M., & Glantz, S.A. (2010). Health effects of light and intermittent smoking: A review. Circulation, 121, 1518-1522.
85. Schnoll, R.A., Martinez, E., Tatum, K.L., Glass, M., Bernath, A., Ferris, D., & Reynolds, P. (2011). Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment. Addictive Behaviors, 36, 144-147.
86. Shapiro, A.E., Tshabangu, N., Golub, J.E., & Martinson, N.A. (2011). Intention to quit smoking among human immunodeficiency virus infected adults in Johannesburg, South Africa. The International Journal of Tuberculosis and Lung Disease, 15, 140-142.
87. Shuter, J., & Bernstein, S.L. (2008). Cigarette smoking is an independent predictor nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine & Tobacco Research, 10, 731-736.
88. Shuter, J., Bernstein, S.L., & Moadel, A.B. (2012a). Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. American Journal of Health Behavior, 36, 75-85.
89. Shuter, J., Salmo, L.N., Shuter, A.D., Nivasch, E.C., & Moadel, A.B. (2012b). Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: A national survey. AIDS and Behavior, 16, 288-294.
90. Sigel, K., Wisnivesky, J., Gordon, K., Dubrow, R., Justice, A., Brown, S.T., ... Crothers, K. (2012). HIV as an independent risk factor for incident lung cancer. AIDS, 26, 1017-1025.
91. Slemmer, J.E., Martin, R.M., & Damaj, M.I. (2000). Bupropion is a nicotinic antagonist. Journal of Pharmacology and Experimental Therapeutics, 295, 321-327.
92. Stead, L.F., & Lancaster, T. (2007). Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews, Issue 3. Article Number: CD005231.
93. Stead, L.F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008). Nicotine replacement therapy for smoking cessation. Cocharane Database of Systematic Reviews, 1. Retrieved from http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000146/frame.html.
94. Stewart, D.W., Jones, G.N., & Minor, K.S. (2012). Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behavioral Medicine, 37, 77-80.
95. Tesoriero, J.M., Gieryic, S.M., Carrascal, A., & Lavigne, H.E. (2010). Smoking among HIV positive New Yorkers: Prevalence, frequency, and opportunities for cessation. AIDS and Behavior, 14, 824-835.
96. Tønnesen, P., Carrozzi, L., Fagerström, K.O., Gratziou, C., Jimenez-Ruiz, C., Nardini, S., ... West, R. (2007). Smoking cessation in patients with respiratory diseases: A high priority, integral component of therapy. European Respiratory Journal, 29, 390-417.
97. Tornero, C., & Mafé, C. (2006). Varenicline and antiretroviral therapy in patients with HIV. Journal of Acquired Immune Deficiency Syndrome, 52, 656.
98. Turner, J., Page-Shafer, K., Chin, D.P., Osmond, D., Mossar, M., Markstein, L., ... Chesney, M. (2001). Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care and STDS, 15, 615-624.
99. Unger, J.B., & Chen, X. (1999). The role of social networks and media receptivity in predicting age of smoking initiation: A proportional hazard model of risk and protective factors. Addictive Behaviors, 24, 371-381.
100. Vidrine, D.J., Arduino, R.C., Lazev, A.B., & Gritz, E.R. (2006). A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS, 20, 253-260.
101. Vidrine, D.J., Marks, R.M., Arduino, R.C., & Gritz, E.R. (2011). Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine & Tobacco Research, 14, 106-110.
102. Webb, M.S., Vanable, P.A., Carey, M.P., & Blair, D.C. (2009). Medication adherence in HIV-infected smokers: The mediating role of depressive symptoms. AIDS Education and Prevention, 21, 94-105.
103. Wewers, M.E., Neidig, J.L., & Kihm, K.E. (2000). The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. Journal of the Association of Nurses in AIDS Care, 11, 37-44.
104. World Health Organization (WHO). (2011). WHO Report on the Global Tobacco Epidemic, 2011: Warning about the dangers of tobacco. Retrieved from http://whqlibdoc.who.int/publications/2011/9789240687813-eng.pdf.
105. Yuan, Y., L'Italien, G., Mukherjee, J., & Iloeje, U.H. (2006). Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Medicine, 7, 156-162.
106. Ziedonis, D., Hitsman, B., Beckham, J.C., Zvolensky, M., Adler, L.E., Audrain-McGovern, J., ... Riley, W.T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research, 10, 1691-1715.
107. Zhu, S.H., Melicer, T., Sun, J., Rosbrook, B., & Pierce, J.P. (2000). Smoking cessation with and without assistance: A population-based analysis. American Journal of Preventative Medicine, 18, 305-311.